Wednesday Jan 25 | Sys-Con Media
Market Research: Antipsychotics Market Will Contract to $14 Billion by 2017
For more information, visit http://www.marketresearch.com/GBI-Research-v3759/Antipsychotics-Patent-Expiries-Zyprexa-Abilify-6768942/ Antipsychotic drugs remain the standard care for the treatment of mental disorders such as schizophrenia and bipolar disorder.
UPDATE 2-FDA extends review of Alexza product, shares fall
Alexza Pharmaceuticals Inc said U.S. health regulators extended the review date for its novel anti-psychotic treatment by three months after the company amended its approval application , sending its shares down as much as 19 percent.
Data show link between diabetes and psych drug
New data from the Vermont Department of Mental Health appear to square with studies elsewhere linking several drugs used to treat mental illnesses to a higher risk for diabetes.
Head-to-head comparisons of metabolic side effects of second...
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis by: Christine Rummel-Kluge , Katja Komossa , Sandra Schwarz , Heike Hunger , Franziska Schmid , Claudia A. Lobos , Werner Kissling , John M. Davis , Stefan Leucht The metabolic side effects ... (more)
Also on Topix